...
首页> 外文期刊>World Journal of Gastroenterology >Hepatic adenomatosis associated with hormone replacement therapy and hemosiderosis: a case report.
【24h】

Hepatic adenomatosis associated with hormone replacement therapy and hemosiderosis: a case report.

机译:与激素替代疗法和铁血黄素沉着症相关的肝腺瘤病:一例报告。

获取原文
获取原文并翻译 | 示例
           

摘要

We have reported a case of hepatic adenomatosis associated with hormone replacement therapy (estrogen and progesterone) and hemosiderosis caused by excessive blood transfusion for the treatment of chronic myeloid leukemia. A 34-year-old woman was found to have several hepatic tumors on a routine medical examination. The general condition was good. Laboratory studies showed iron overload. Abdominal computed tomography and selective hepatic angiography showed several hypervascular tumors in the right lobe of the liver (up to 20 mm in diameter). Since hepatocellular carcinoma could not be ruled out, subsegmental hepatectomy was performed. Histopathological examination of the surgical specimen showed hepatic adenomatosis with hemosiderosis. Both hormone replacement therapy and iron overload could be the cause of hepatic adenomatosis.
机译:我们已经报道了一例肝腺瘤病,伴有激素替代疗法(雌激素和孕酮)和铁血过多,由过量输血引起,用于治疗慢性粒细胞白血病。在常规医疗检查中,发现一名34岁妇女患有数种肝肿瘤。总体情况还不错。实验室研究表明铁超载。腹部计算机断层扫描和选择性肝血管造影显示在肝右叶(直径最大20毫米)中有数个血管过度肿瘤。由于不能排除肝细胞癌,因此进行了节段性肝切除术。手术标本的组织病理学检查显示伴有铁血黄素沉着症的肝腺瘤病。激素替代疗法和铁超负荷均可能是肝腺瘤病的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号